You are not currently logged in
| Local | |
| GMT |
Pharmacovigilance
The detection, assessment, understanding and prevention of adverse effects of pharmaceutical products is a critical issue in the European healthcare market.
APM Health Europe provides comprehensive coverage of pharmacovigilence issues.
View the latest pharmacovigilence news here…
Third promising Phase III results for Vertex’ telaprevir in HCV 09/09/2010 09:55 GMT
- CHMP quizzes GSK over Avandia and examines Pandemrix narcolepsy risk 09/09/2010 07:29 GMT
- Pharma warns EMA not to overplay importance of ethics in clinical trials 08/09/2010 07:24 GMT
- France's Prescrire lodges complaint against EMA over transparency 07/09/2010 12:47 GMT
- FDA rejects EMA's call to compel companies to insure trial volunteers 06/09/2010 13:05 GMT
- GSK 'regrets' secretly-taped Avandia comments might be misinterpreted 06/09/2010 12:27 GMT
- English press review - weekend & Monday 06/09/2010 10:40 GMT
- MHRA says UK drug safety experts advised in July Avandia should be pulled 06/09/2010 09:49 GMT
- Oral bisphosphonates linked to risk of oesophageal cancer 03/09/2010 12:50 GMT
- Abbott offers more evidence of cardiac risks with diet drug Meridia 03/09/2010 07:09 GMT
1 
